Roblox’s September Report Card Shows Improvement

Summer is over, so kids are back to school, and adults are back to their regular routines. Unfortunately, for companies like Roblox, which rely heavily on a younger demographic, this often means trouble for their business metrics. 

The last time we spoke about Roblox was in August when the company reported lower-than-expected earnings and revenue numbers. In addition, its daily active users (DAUs) came in at 52.2 million, nearly a million less than expected. Since then, the stock has continued to fall with the rest of the market.

Today, the company released its September “report card,” so let’s take a look at how it did. 🧐

September’s daily active users (DAUs) rose to 57.8% million, up 23% YoY and hours engaged were also up 16% YoY to 4 billion. Yes, that’s a “B” as in “boy, that’s a lot of gaming.”

Additionally, its estimated bookings were up between 11%-15% YoY, or $212 and $219 million.

While all of these numbers fell from August, many had expected worse declines as children returned to school. 👍

From a stock perspective, short interest was roughly 6.20% of outstanding shares, marginally lower than its all-time high of around 7.2% in July. When you combine better-than-expected news with a rebounding market and high short interest; you get a squeeze.

And that’s exactly what’s happening today in $RBLX shares as they rally over 20%. 📈

There are two *schools* of thought regarding the stock’s longer-term chart.

Bullish technical analysts say the stock is “building” on its long-term bottom formation here by forming a higher low of support. 🐂

Meanwhile, bearish analysts say a downward-sloping 200-day moving average indicates the long-term trend is still down and should act as resistance as prices approach it. 🐻

Bulls clearly have the upper hand today, but who is ultimately right remains to be seen. While we wait, head over to the $RBLX stream and share your thoughts!

Biotech Buyout Spree Continues

It may be the last week of the year, but many companies are rushing to get deals done before year-end. Two significant transactions in the biotech space were announced today, so let’s dive in. 👇

The first deal involves RayzeBio, which raised $358 million via an initial public offering (IPO) just three months ago. However, its time as a public company is being cut short by Bristol Myers Squibb, which is acquiring the radiopharmaceutical therapeutics company for $62.50 per share in cash. 💰

Read It

Chinese Smartphone Maker Unveils EV

Chinese smartphone giant Xiaomi is entering the highly competitive electric vehicle (EV) market, revealing its first electric car this weekend. 👀

The consumer electronics company unveiled its SU7 sedan, which it says it spent more than $1.4 billion to develop. The vehicle is set to roll out in China next year and is attempting to do something Faraday Future and other competitors have failed to do: create a software-focused vehicle that matches the technology people find in their phones to what’s happening in their cars. 

Read It

A Chip Off The Holiday News Flow

It’s a slow week in the market, but as usual, there’s some news out of the semiconductor space. Let’s take a look. 👀

First up is Israel granting Intel $3.2 billion to support the company’s biggest investment in the country. Intel will not only build a $25 billion factory that creates thousands of jobs but will also buy $16.6 billion in goods and services from Israeli suppliers over the next decade. It is anticipated that the plant will open in 2028 and operate through at least 2035. 🏭

Read It

Boeing Loses Altitude (Again)

If you’re an investor in airlines or airplane manufacturers, this is not the type of headline you want to wake up to. Unfortunately for Boeing and several others, the news is not great. So let’s dig into it. 👇

Read It